Sloan Kettering Secures Sanctions In Drug IP Case

By Shayna Posses · June 6, 2017, 3:17 PM EDT

A New York magistrate judge sanctioned a biopharmaceutical company and its counsel Monday for using protected information from its now-dismissed lawsuit against the Sloan Kettering Institute for Cancer Research over gene...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Order

Case Information

Case Title

Errant Gene Therapeutics, LLC et al v. Sloan-Kettering Institute for Cancer Research

Case Number

Court

New York Southern

Nature of Suit

Patent

Date Filed

March 18, 2015

Recent Articles By Shayna

July 22, 2019
Feds Must Hand Over Info In Eye Product Kickback Suit
June 28, 2019
Medtronic Insulin Pumps Yanked For Possible Hacking Threat
June 14, 2019
8 Men Charged Over Compounding Drug Kickbacks
June 06, 2019
Ex-Shire Unit Exec Reaches $2.5M Deal In Kickback Case
May 31, 2019
Premera Blue Cross Floats $32M Deal In Data Breach Row
March 25, 2019
Sports Court Delays Female Testosterone Rule Decision
March 14, 2019
Georgetown Hospital Med Mal Suit Was Too Late, Panel Says
March 06, 2019
FCA Claim Rightly Axed In $70M Kickback Suit, Judge Says
February 21, 2019
Couple Found Guilty Of $1M Medicaid, Payroll Tax Scheme
January 30, 2019
Dialysis Center Agrees To $3.25M Deal In Kickback Suit